title: Health-related quality of life in men with metastatic castration-resistant prostate cancer.
abstract: Metastatic castration-resistant prostate cancer (MCRPC) is a chronic disease with several therapeutic options. By definition, all approaches to treatment are palliative in intent and improving health-related quality of life (HRQoL) is an important goal of therapy. Several tools exist for the assessment of HRQoL in MCRPC enabling cross-trial comparisons. In this article agents currently used in the management of MCRPC are reviewed from a HRQoL perspective.
authors.affiliation: a Bristol Haematology and Oncology Centre , University Hospitals Bristol NHS Foundation Trust , Bristol , UK.
authors.forename: Abigail
authors.initials: A
authors.lastname: Gee
authors.affiliation: a Bristol Haematology and Oncology Centre , University Hospitals Bristol NHS Foundation Trust , Bristol , UK.
authors.forename: Amarnath
authors.initials: A
authors.lastname: Challapalli
authors.affiliation: a Bristol Haematology and Oncology Centre , University Hospitals Bristol NHS Foundation Trust , Bristol , UK.
authors.forename: Amit
authors.initials: A
authors.lastname: Bahl
mesh_terms: D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D010166:Palliative Care / Q000379:methods*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000473:pathology / Q000628:therapy*; D011788:Quality of Life
keywords: Prostate cancer; castrate-resistant; health related quality of life; pain; patient reported outcomes